- Home
- TRVI vs ZURA Comparison
TRVI vs ZURA Comparison
Compare TRVI & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- ZURA
- Stock Information
- Founded
- TRVI 2011
- ZURA 2022
- Country
- TRVI United States
- ZURA United States
- Employees
- TRVI N/A
- ZURA N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRVI Health Care
- ZURA Health Care
- Exchange
- TRVI Nasdaq
- ZURA Nasdaq
- Market Cap
- TRVI 341.4M
- ZURA 292.1M
- IPO Year
- TRVI 2019
- ZURA N/A
- Fundamental
- Price
- TRVI $3.76
- ZURA $1.77
- Analyst Decision
- TRVI Strong Buy
- ZURA Buy
- Analyst Count
- TRVI 8
- ZURA 6
- Target Price
- TRVI $9.31
- ZURA $15.80
- AVG Volume (30 Days)
- TRVI 659.4K
- ZURA 613.7K
- Earning Date
- TRVI 11-06-2024
- ZURA 03-12-2025
- Dividend Yield
- TRVI N/A
- ZURA N/A
- EPS Growth
- TRVI N/A
- ZURA N/A
- EPS
- TRVI N/A
- ZURA N/A
- Revenue
- TRVI N/A
- ZURA N/A
- Revenue This Year
- TRVI N/A
- ZURA N/A
- Revenue Next Year
- TRVI N/A
- ZURA N/A
- P/E Ratio
- TRVI N/A
- ZURA N/A
- Revenue Growth
- TRVI N/A
- ZURA N/A
- 52 Week Low
- TRVI $1.27
- ZURA $1.76
- 52 Week High
- TRVI $4.68
- ZURA $6.35
- Technical
- Relative Strength Index (RSI)
- TRVI 48.03
- ZURA 30.04
- Support Level
- TRVI $3.63
- ZURA $1.86
- Resistance Level
- TRVI $4.06
- ZURA $2.08
- Average True Range (ATR)
- TRVI 0.30
- ZURA 0.21
- MACD
- TRVI -0.09
- ZURA -0.03
- Stochastic Oscillator
- TRVI 12.21
- ZURA 1.55
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About ZURA Zura Bio Limited
Zura Bio Ltd is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders.